Selecting end points in clinical trials: What evidence do we really need to evaluate a new treatment?
- PMID: 11685157
- DOI: 10.1067/mhj.2001.119135
Selecting end points in clinical trials: What evidence do we really need to evaluate a new treatment?
Comment on
-
Advanced coronary artery disease: Appropriate end points for trials of novel therapies.Am Heart J. 2001 Nov;142(5):843-51. doi: 10.1067/mhj.2001.119136. Am Heart J. 2001. PMID: 11685173
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
